Follow the 4Front Ventures Corp. share price and the full directors' dealings record of the company, a listed equity based in United States. Shares trade on the US market, under the authority of SEC (Form 4). Operating in the Health Care sector, 4Front Ventures Corp. has published 26 reports. Market capitalisation: €9k. The latest transaction was filed on 22 April 2025 (Attribution). Among the most active insiders: GULATI CHETAN. The full history is accessible without an account.
26
Insider Decl.
n/a
Thresholds
€1,668
5 ops.
Buy Volume
€4,796
4 ops.
Sell Volume
36Σ signal
Buys €1,668€4,796 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
154,038 sharesClass A Subordinate Voting SharesSEC:0000899243-22-021321:1
Canonical exit: 12 Jul 2022 (T+90)
25 of 26 declarations
About 4Front Ventures Corp.
4Front Ventures Corp. is a company in the health and pharmaceutical sector, focused on the development and distribution of cannabis-related products. It is listed on NASDAQ under the symbol XNAS.